IXUS vs XBI
iShares Core MSCI Total International Stock ETF vs SPDR S&P Biotech ETF
- • IXUS has the lower expense ratio at 0.07% vs 0.35% for XBI.
- • IXUS pays a higher dividend yield (2.94%).
Side-by-side metrics
| Metric | IXUS | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.94% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $58.52B | $10.73B |
YTD return | 12.78% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 1.10 |
P/E ratio | 18.28 | — |
Last price | $95.06 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
IXUS top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 4.36% |
| 005930.KS | Samsung Electronics Co Ltd | 2.36% |
| 000660.KS | SK Hynix Inc | 2.21% |
| ASML.AS | ASML Holding NV | 1.79% |
| 0700.HK | Tencent Holdings Ltd | 0.79% |
| HSBA.L | HSBC Holdings PLC | 0.76% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 0.68% |
| NOVN.SW | Novartis AG Registered Shares | 0.67% |
| RY | Royal Bank of Canada | 0.67% |
| AZN.L | AstraZeneca PLC | 0.66% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About IXUS
IXUS (iShares Core MSCI Total International Stock ETF) is Non-US equities across developed and emerging markets. Managed by iShares, the fund carries $58.5B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.94%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 4.4% of the portfolio. Real Estate is the fund's largest sector exposure at 2.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.